Location
Headquarters: Tokyo, Tokyo, Japan, Asia
Region: Tokyo
Country: JP
Continent: Asia
About
Takeda is a global biopharmaceutical company focused on discovering and developing medicines across multiple areas including oncology, immunology, hematology, vaccines, and rare diseases. With R&D-driven science and a patient-centric approach, the company aims to bring Better Health and a Brighter Future to people worldwide, with operations spanning its headquarters in Japan and presence across global markets.
Takeda is a global biopharmaceutical company that discovers and develops medicines in oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. Its products include Entyvio for ulcerative colitis, Ninlaro for multiple myeloma, and Gammagard Liquid for primary immunodeficiency. The company operates in over 80 countries.
Takeda Pharmaceutical Company Limited.
1781
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Grant
7500000000
over-1b
ipo
TAK
nasdaq
Investors
Founders
Bruno Villetelle
Chobei Takeda I
Leadership
Schuyler Fairfield — SVP, Global Head of Supply Chain
Henry Werner — Communication Director Nordics & Baltics
Christopher Barr — Head of corporate social responsibility and philanthropy
Anastasia Ashirova — Digital Business Partner
Bin Li — Senior Director, Computational Biology
Patrycja Lakomiak — Head Of Supply Chain Coordination
Hidemasa Tanigaki — Gastrointestinal Business Unit Head
Technology Stack
Products
Adcetris® (brentuximab vedotin): A pharmaceutical drug used to treat certain types of lymphoma by targeting and killing cancer cells.
Plasma-Derived Therapies: Therapies developed from human plasma to treat rare and complex chronic diseases.
Gastrointestinal and Inflammation Treatments: Pharmaceutical treatments targeting gastrointestinal and inflammatory diseases.
Rare Diseases Treatments: Medicines for immunology, hematology, metabolic, and lysosomal storage disorders classified as rare diseases.
Oncology Treatments: Medicines developed to treat various types of cancer, including targeted therapies and chemotherapy agents.
Neuroscience Treatments: Pharmaceutical products aimed at treating neurological diseases and disorders.